Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study.
Liu D, Kou F, Gong J, Wang Z, Zhang X, Li J, Li Y, Li J, Zhou J, Lu M, Wang X, Lu Z, Cao Y, Zou J, Zhu X, Xu R, Shen L.
Liu D, et al. Among authors: zhu x.
Cancer Med. 2023 May;12(9):10704-10714. doi: 10.1002/cam4.5830. Epub 2023 Apr 20.
Cancer Med. 2023.
PMID: 37081722
Free PMC article.
Clinical Trial.